Cheng Woei Ping, Gray Alexander I, Tetley Laurence, Hang Thi Le Bich, Schätzlein Andreas G, Uchegbu Ijeoma F
Department of Pharmaceutical Sciences, Strathclyde Institute for Biological Sciences Building, University of Strathclyde, 27 Taylor Street, Glasgow G4 0NR, UK.
Biomacromolecules. 2006 May;7(5):1509-20. doi: 10.1021/bm060130l.
In the pharmaceutical industry, orally active compounds are required to have sufficient water solubility to enable dissolution within the gastrointestinal tract prior to absorption. Limited dissolution within the gastrointestinal tract often reduces the bioavailability of hydrophobic drugs. To improve gastrointestinal tract dissolution, nonaqueous solvents are often used in the form of emulsions and microemulsions. Here, we show that oil-free polyelectrolyte nanosystems (micellar dispersions and 100-300 nm particles) prepared from poly(ethylenimines) derivatized with cetyl chains and quaternary ammonium groups are able to encapsulate high levels of hydrophobic drug (0.20 g of drug per g of polymer) for over 9 months, as demonstrated using cyclosporine A (log P = 4.3). The polyelectrolytes facilitate the absorption of hydrophobic drugs within the gastrointestinal tract by promoting drug dissolution and by a hypothesized mechanism involving paracellular drug transport. Polyelectrolyte nanoparticle drug blood levels are similar to those obtained with commercial microemulsion formulations. The polyelectrolytes do not promote absorption by inhibition of the P-glycoprotein efflux pump.
在制药行业,口服活性化合物需要有足够的水溶性,以便在吸收前在胃肠道内溶解。在胃肠道内有限的溶解通常会降低疏水性药物的生物利用度。为了改善胃肠道溶解,非水溶剂通常以乳液和微乳液的形式使用。在此,我们表明,由十六烷基链和季铵基团衍生化的聚乙烯亚胺制备的无油聚电解质纳米系统(胶束分散体和100 - 300 nm颗粒)能够在9个月以上的时间内包封高水平的疏水性药物(每克聚合物0.20克药物),使用环孢素A(log P = 4.3)证明了这一点。聚电解质通过促进药物溶解以及通过一种涉及细胞旁药物转运的假设机制,促进胃肠道内疏水性药物的吸收。聚电解质纳米颗粒药物的血药浓度与商业微乳液制剂所获得的血药浓度相似。聚电解质不会通过抑制P - 糖蛋白外排泵来促进吸收。